With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic ...

Three times as many deaths in the study arm versus the control arm in a trial of ADC Therapeutics' Zynlonta have raised ...

With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its ...

Medical device distribution giant Medline was slammed for a second time since April by an FDA warning letter that chided the company for repeated problems centered on the presence of toxic bacteria in ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government ...

The pharma marketing world has unique insight into how words play into their world: Many months and many dollars are spent ...

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions ...

Amid shifts in attitudes around family planning and contraception—and as the advent of telehealth outfits like Hims & Hers ...

After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate ...

There were 487 exhibitor booths at the American Society of Clinical Oncology (ASCO)’s 2026 annual meeting, held in Chicago’s McCormick Place. Fierce Pharma Marketing attempted to see each one. Jazz's ...

The nonprofit, The Endometriosis Collective, has included Schumer and Monroe in the feature-length documentary “End of the ...